Mezey and Fulmer (2002) justify gerontological nursing research and the work of geron-tological advanced-practice nurses by concluding the following:
a. Gerontological nursing research is devalued by other scientists.
b. The research influences outcomes from nursing care in a positive way.
c. Gerontological care is expensive but required in long-term care.
d. Gerontological nursing research is well-known to practicing nurses.
B
Feedback
A Incorrect. The research is widely accepted by the scientific community.
B Correct. The practices of advanced-practice nurses, who base their practice on nursing research, have resulted in positive elder outcomes and cost-effectiveness.
C Incorrect. Advanced-practice nurses generate positive outcomes and are cost-effective in many settings.
D Incorrect. Mezey and Fulmer feel the goal of gerontological nursing is to disse-minate the knowledge from gerontological nursing research to all nurses and to have the knowledge applied to their practice.
You might also like to view...
A nurse is caring for a patient who has pneumonia. To facilitate respiration and lung drainage this patient should be placed in what position?
a. Sims' b. Prone c. Lateral d. Supine
The school nurse is working with a pregnant adolescent. The nurse will advise the young woman to eat foods high in iron and also high in which of the following vitamins to increase the absorption of iron?
a. the B vitamins c. vitamin C b. vitamin E d. vitamin D
Disasters affect communities physically and emotionally. The first goal in any disaster is
1. To clean-up of the environment 2. Handling stress reaction 3. Bringing in as many aid workers and nurses as possible to the area 4. To reestablish sanitary barriers and focus on basic needs
A patient who has RA has been taking methotrexate for 6 months and tells the primary care NP that symptoms seem to be getting worse. The NP refers the patient back to the rheumatologist and should expect the rheumatologist to:
a. add prednisone to the drug regimen. b. add adalimumab to the drug regimen. c. change to a combination of adalimumab and etanercept. d. discontinue methotrexate because 50% of patients do not respond.